HIV and Organ Transplantation: Addressing equity and Barriers

Solid organ transplantation offers a life-saving treatment for individuals with end-stage organ failure.though, equitable access to this therapy remains a significant global challenge.A recent Lancet Series emphasizes the urgent need to advance equity in transplantation, and highlights specific barriers faced by people living with HIV.

Despite advancements in antiretroviral therapy (ART) that have dramatically improved life expectancy and quality of life for those with HIV, individuals with HIV encounter unique obstacles when seeking organ transplantation. These barriers are often complex and intersect with existing inequalities in healthcare access.

Achieving equity in organ transplantation for people with HIV is crucial for reaching the UNAIDS fourth 90 target. This goal focuses on optimizing the overall health-related quality of life and promoting healthy longevity for all people living with HIV. Simply put, access to transplantation isn’t just about extending life; it’s about ensuring a full and healthy life.

The Lancet Series identifies numerous systemic obstacles to solid organ transplantation globally. For people with HIV, these are compounded by stigma, discriminatory policies, and a lack of specialized expertise among transplant teams. These factors can lead to delayed evaluations, exclusion from transplant lists, and ultimately, reduced access to this potentially life-saving treatment.

Addressing these inequities requires a multi-faceted approach. This includes educating healthcare professionals, revising transplant policies to remove discriminatory practices, and increasing research focused on the outcomes of transplantation in people with HIV. Furthermore, fostering a supportive and non-stigmatizing environment is essential to ensure that all individuals, nonetheless of their HIV status, have a fair opportunity to benefit from solid organ transplantation.

Ultimately, ensuring equitable access to organ transplantation for people with HIV is a matter of social justice and public health. It’s a vital step towards achieving global health equity and fulfilling the promise of long and healthy lives for everyone living with HIV.